Australia’s TGA Considers Electronic Submissions for Exported Drugs
Australia’s Therapeutic Goods Administration (TGA) is requesting feedback from stakeholders on whether it should allow electronic submission of their export documents.
The agency is interested in allowing the electronic option alongside a certificate of pharmaceutical product (CPP) or a certificate of listed product (CLP) application.
The TGA currently requires applicants to provide hard copies for all export documents because imported countries required them more than 15 years ago.
The consultation period ends on Feb. 3, 2020.